Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOTANIX PHARMACEUTICALS LTD Board/Management Information 2017

Feb 16, 2017

64551_rns_2017-02-16_caa6d76f-7995-49a3-ba7e-931ba33e4d96.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [159 x 74] intentionally omitted <==

ASX/Media Release

17 February 2017

Change of Company Secretary and Registered Office

Perth Australia, 17 February 2017: Botanix Pharmaceuticals Limited (“Botanix” or “The Company”) announced today that it has appointed Mr Simon Robertson as Company Secretary.

Mr Robertson currently holds the position of Company Secretary for a number of publicly listed companies and has experience in corporate finance, accounting and administration, capital raisings and ASX compliance and regulatory requirements. Mr Robertson is a member of the Institute of Chartered Accountants and the Governance Institute of Australia. Mr Robertson gained a Bachelor of Business from Curtin University in Western Australia and Master of Applied Finance from Macquarie University in New South Wales.

Simultaneously Mr Brett Tucker has resigned as Company Secretary. The Board of Directors thank Mr Tucker for his service to the Company.

Change of Registered Office

The Company also wishes to advise that it has changed the address of its registered office and its new contact details are:

68 Aberdeen Street Northbridge WA 6003

Telephone: 08 6555 2945 Fax: 08 6210 1153

For more information on Botanix, please visit www.botanixpharma.com or follow us on Twitter @Botanixpharma.

For more information, please contact:

General enquiries Investor Relations Matt Callahan Ben Walsh Botanix Pharmaceuticals Ltd WE Buchan Executive Director P: 02 9237 2801 P: +1 215 767 4184 E: [email protected] E: [email protected]

Media enquiries Arthur Chan WE Buchan P: (02) 9237 2805 E: [email protected]